In conclusion, our study showed that IL-4 was decreased in retinal degeneration, and the application of exogenous IL-4 protected the RPE cells and improved neurofunction through anti-oxidative and anti-inflammatory pathways. The gene discussed is IL4; the disease is retinal degeneration.